PrimeRFP SCOUT · Federal Contract Recompete Brief

W81K0024D0001Novation agreement DUE to NAME CHANGE — Quidelortho Sales Company, LLC

Quidelortho Sales Company, LLC holds $16.1M across 283 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 5 related awards in the incumbent pipeline. Set-aside status: NONE.

W40m Mrc0 West

Awarding office

Quidelortho Sales Company, LLC

Recipient

—

Estimated value

6505

PSC

NONE

Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Quidelortho Sales Company, LLC — $90

Contract facts

NONE

Contract numberW81K0024D0001

Also listed asW81K00-24-D-0001

AgencyW40m Mrc0 West

Awarding officeW40m Mrc0 West

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentQuidelortho Sales Company, LLC

UEIZFXRG96JMJ39

PSC6505

Related solicitationW81K0024Q0033

NOVATION AGREEMENT DUE TO NAME CHANGE BETWEEN ORTHO CLINICAL DIAGNOSTICS, INC, CAGE CODE 1C0L5 AND QUIDELORTHO SALES COMPANY, LLC, CAGE CODE 12B04 is a federal NONE award for W40m Mrc0 West held by Quidelortho Sales Company, LLC. Estimated value —. Related solicitation W81K0024Q0033.

NOVATION AGREEMENT DUE TO NAME CHANGE BETWEEN ORTHO CLINICAL DIAGNOSTICS, INC, CAGE CODE 1C0L5 AND QUIDELORTHO SALES COMPANY, LLC, CAGE CODE 12B04

Incumbent footprint

Public record

Quidelortho Sales Company, LLC — $16.1M obligated across 283 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($16.1M) · all agencies

Department of Defense (DOD)$5.9M · 37%Department of Health and Human Services (HHS)$5.7M · 35%Department of Veterans Affairs (VA)$4.4M · 27%Department of Justice (DOJ)$87K · 1%

Open full company profile →

Related awards

Same incumbent

75H71025F80237

COST PER TEST FOR CHEMISTRY ANALYZER FCRHC LABORATORY - MOD 1 ADD FUNDS AND CORRECT POP EN…

$179K

Sep 22, 2026

36C26226F0029

CHEMISTRY IMMUNOCHEMISTRY SYSTEM CPT

$957K

Sep 30, 2026

36C26326N0047

ORTHO IMMUNOCHEMISTRY

$697K

Sep 30, 2026

36C26326N0027

ORTHO IMMUNOCHEMISTRY

$460K

Sep 30, 2026

W81K0026FA019

FY26 CPRR IMMUNOCHEMISTRY ANALYZER (LEASE), AND CLINICAL CHEMISTRY ANALYZER (LEASE) - GLWA…

$369K

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W81K0024D0001?

W81K0024D0001 (Novation agreement DUE to NAME CHANGE) is a W40m Mrc0 West award with an estimated value of —, currently held by Quidelortho Sales Company, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W81K00-24-D-0001?

W81K00-24-D-0001 is the dashed form of PIID W81K0024D0001 (Novation agreement DUE to NAME CHANGE), held by Quidelortho Sales Company, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W81K0024D0001?

W40m Mrc0 West awarded W81K0024D0001 to Quidelortho Sales Company, LLC.

Who is the incumbent on W81K0024D0001?

Quidelortho Sales Company, LLC is the incumbent with $16.1M across 283 related awards in SCOUT’s public footprint.

When does Quidelortho Sales Company, LLC’s W81K0024D0001 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthly